Biosurgery Market Worth USD 15.58 billion: Increasing Volume of Surgeries and Prevalence of Severe Trauma Injuries

Pune, India, 2020-Apr-28 — /EPR Network/ —

The major factors that are expected to be driving the biosurgery market are the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients. The objective of the report is to define, describe, and forecast the biosurgery market size based on product, application, and region.

The biosurgery market to grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a Compound Annual Growth Rate (CAGR) of 6.5%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302

1. Bone-Graft Substitutes
2. Soft-Tissue Attachments
3. Hemostatic Agents
4. Surgical Sealants and Adhesives
5. Adhesion Barriers
6. Staple-Line Reinforcement Agents

Applications of Biosurgery Market:

1. Orthopedic Surgery
2. General Surgery
3. Neurological Surgery
4. Cardiovascular Surgery
5. Reconstructive Surgery
6. Gynecological Surgery
7. Urological Surgery
8. Thoracic Surgery

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East and Africa

North America is expected to hold the largest market size in the biosurgery market during the forecast period. The highest market share of North America is due to the presence of a well-developed healthcare system, increasing volume of surgical procedures performed, large number of hospitals, and presence of leading market players in the region. The Asia Pacific market is expected to witness the highest growth rate during the forecast period.

Key Players:

Baxter International (US), Johnson & Johnson (J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global biosurgery market. Some of the other leading players in this market include Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife Inc. (US).